Antiangiogenic agents and endothelin antagonists in advanced castration resistant prostate cancer.

@article{Merino2011AntiangiogenicAA,
  title={Antiangiogenic agents and endothelin antagonists in advanced castration resistant prostate cancer.},
  author={Mar{\'i}a Merino and A. F. F. Pinto and Ra{\'u}l A Morales Gonz{\'a}lez and Enrique Espinosa},
  journal={European journal of cancer},
  year={2011},
  volume={47 12},
  pages={
          1846-51
        }
}
Despite multiple advances in prostate cancer therapy, treatment options for castration resistant disease are very limited. While data from recent studies are encouraging, there is no drug that has significantly improved results of standard chemotherapy. Some of the most consistent results are provided by antiangiogenic agents, showing high response rates and manageable toxicity. We describe some of the main therapeutic angiogenesis inhibitors in metastatic castration resistant prostate cancer… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Similar Papers

Loading similar papers…